Ideal Medical Products accepts buyout deal
This article was originally published in The Gray Sheet
Executive Summary
Private equity fund HealthpointCapital acquires Paris-based Ideal Medical Products, the principal shareholder of spinal implant developer Scient'X. The two-step deal calls for the payment of $62 million to acquire the privately held Ideal Medical shares controlled by the Carli family, followed by initiation of a tender offer for the publicly held, minority interest in the company at $31.81 per share. Spinal fusion device maker Alphatec had sought to buy Scient'X in 2006 for $180 million, but the deal was later scuttled in favor of a licensing deal for Scient'X flagship dynamic stabilization product portfolio. HealthpointCapital, which also is Alphatec's principal stockholder, notes that this deal "will allow our firm to directly invest in and grow Scient'X" (1"The Gray Sheet" Jan. 29, 2007, p. 15)